Literature DB >> 6541965

Plasma exchange in thrombotic thrombocytopenic purpura.

E B Toffelmire, W F Clark, P E Cordy, A L Linton, R C Lohmann.   

Abstract

Three patients were recently treated for thrombotic thrombocytopenic purpura (TTP). One presented with toxic shock syndrome; TTP developed but promptly responded to a regimen of antiplatelet agents, steroids and plasma exchange. In another the manifestations of TTP developed after presentation with hypertension and abdominal pain. This patient responded to a similar regimen but required extended treatment before remission could be maintained with medications alone. In the third patient the full TTP syndrome appeared after several days of plasma exchange treatment for hemolyticuremic syndrome. He did not respond. It is suggested that TTP may present in many forms initially, that microangiopathic hemolysis may be a late manifestation and that the optimal therapy is not known.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6541965      PMCID: PMC1483661     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN: 0008-4409            Impact factor:   8.262


  34 in total

1.  Thrombotic thrombocytopenic purpura--a deficiency of plasma factors regulating platelet-vessel-wall interaction?

Authors:  G Remuzzi; R Misiani; G Mecca; G de Gaetano; M B Donati
Journal:  N Engl J Med       Date:  1978-08-10       Impact factor: 91.245

Review 2.  The membrane actions of anesthetics and tranquilizers.

Authors:  P Seeman
Journal:  Pharmacol Rev       Date:  1972-12       Impact factor: 25.468

3.  Aspirin and prednisone in microangiopathic haemolytic anaemia.

Authors:  F Jobin; J M DeLage
Journal:  Lancet       Date:  1970-07-25       Impact factor: 79.321

4.  Platelet and fibrinogen consumption in man.

Authors:  L A Harker; S J Slichter
Journal:  N Engl J Med       Date:  1972-11-16       Impact factor: 91.245

5.  Treatment of thrombotic thrombocytopenic purpura with plasma.

Authors:  J J Byrnes; M Khurana
Journal:  N Engl J Med       Date:  1977-12-22       Impact factor: 91.245

6.  Plasmapheresis in the treatment of thrombotic thrombocytopenic purpura.

Authors:  R M Bukowski; J W King; J S Hewlett
Journal:  Blood       Date:  1977-09       Impact factor: 22.113

7.  Gingival biopsy in thrombotic thrombocytopenic purpura.

Authors:  A Goodman; R Ramos; M Petrelli; S A Hirsch; R Bukowski; J W Harris
Journal:  Ann Intern Med       Date:  1978-10       Impact factor: 25.391

8.  Thrombotic thrombocytopenic purpura fails to respond to fresh frozen plasma infusion.

Authors:  J Ansell; R S Beaser; L Pechet
Journal:  Ann Intern Med       Date:  1978-11       Impact factor: 25.391

9.  Antiplatelet treatment of thrombotic thrombocytopenic purpura.

Authors:  E L Amorosi; S Karpatkin
Journal:  Ann Intern Med       Date:  1977-01       Impact factor: 25.391

10.  The hemolytic-uremic syndrome is a syndrome.

Authors:  B S Kaplan; K N Drummond
Journal:  N Engl J Med       Date:  1978-04-27       Impact factor: 91.245

View more
  1 in total

Review 1.  TTP: From empiricism for an enigmatic disease to targeted molecular therapies.

Authors:  Nuno A G Graça; Bérangère S Joly; Jan Voorberg; Karen Vanhoorelbeke; Nicolas Béranger; Agnès Veyradier; Paul Coppo
Journal:  Br J Haematol       Date:  2022-02-10       Impact factor: 8.615

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.